Simultaneous quantification of oleuropein and its metabolites in rat plasma by liquid chromatography electrospray ionization tandem mass spectrometry

Biomedical Chromatography

Volumn 24, Issue 5, 2010, Pages 506-515

  Bazoti, Fotini N ^a,b   Gikas, Evangelos ^b   Tsarbopoulos, Anthony ^a,b  

^a UNIVERSITY OF PATRAS   (Greece)

^b Goulandris Natural History Museum   (Greece)

Author keywords

Electrospray tandem mass spectrometry; Hydroxytyrosol; Liquid chromatography; Oleuropein; Plasma

Indexed keywords

ACETIC ACID; BIOCHEMISTRY; BIOMOLECULES; BODY FLUIDS; ELECTRODES; ELECTROSPRAY IONIZATION; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OLIVE OIL; PH; PHASE SEPARATION; PHOSPHOLIPIDS; POSITIVE IONS; RATS;

BIOACTIVE COMPOUNDS; ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY; ELECTROSPRAY TANDEM MASS SPECTROMETRY; HYDROXYTYROSOL; LC-ESI-MS/MS; LC/ESI-MS/MS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; OLEUROPEIN; QUANTIFI CATIONS; RAT PLASMA;

METABOLITES;

3,4 DIHYDROXYPHENYLACETIC ACID; 4 (2 HYDROXYETHYL) 2 METHOXYPHENOL; ELENOLIC ACID; HOMOVANILLIC ACID; HOMOVANILLYL ALCOHOL; HYDROXYTYROSOL; OLEUROPEIN; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG METABOLISM; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; LIQUID CHROMATOGRAPHY; METABOLITE; MOLECULAR SIZE; NONHUMAN; PLASMA; RAT; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

OLEA EUROPAEA; RATTUS;

EID: 77951711851     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1319     Document Type: Article

References (54)

1. Aziz NH, Farag SE, Mousa LA and Abo-Zaid MA. Comparative antibacterial and antifungal eff ects of some phenolic compounds. Microbios 1998; 93: 43-54.
2. Bai C, Yan X, Takenaka M, Sekiya K and Nagata T. Determination of synthetic hydroxytyrosol in rat plasma by GC-MS. Journal of Agricultural and Food Chemistry 1998; 46: 3998-4001. (Pubitemid 128488482)
3. Bastianetto S and Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiology of Aging 2002; 23: 891-897. (Pubitemid 35217714)
4. Bazoti FN, Gikas E, Puel C, Coxam V and Tsarbopoulos A. Development of a sensitive and specifi c solid phase extraction-gas chromatography-tandem mass spectrometry method for the determination of elenolic acid, hydroxytyrosol, and tyrosol in rat urine. Journal of Agricultural and Food Chemistry 2005; 53: 6213-6221. (Pubitemid 41169363)
5. Beauchamp GK, Keast RSJ, Morel D, Lin J, Pika J, Han Q, Lee CH, Smith AB and Breslin PAS. Phytochemistry: Ibuprofen-like activity in extra-virgin olive oil. Nature 2005; 437: 45-46. (Pubitemid 41613421)
6. Bisignano G, Tomaino A, Lo Cascio R, Crisafi G, Uccella N and Saija A. On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. The Journal of Pharmacy and Pharmacology 1999; 51: 971-974. (Pubitemid 29431413)
7. Briante R, Patumi M, Terenziani S, Bismuto E, Febbraio F and Nucci R. Olea europaea L. leaf extract and derivatives: antioxidant properties. Journal of Agricultural and Food Chemistry 2002; 50: 4934-4940. (Pubitemid 34856169)
8. Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A and De Caterina R. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arteriosclerosis, Thrombosis, and Vascular Biology 2003; 23: 622-629. (Pubitemid 36438075)
9. Caruso D, Visioli F, Patelli R, Galli C and Galli G. Urinary excretion of olive oil phenols and their metabolites in humans. Metabolism 2001; 50: 1426-1428. (Pubitemid 34007411)
10. Coni E, Di Benedetto R, Di Pasquale M, Masella R, Modesti D, Mattei R and Carlini EA. Protective eff ect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits. Lipids 2000; 35: 45-54. (Pubitemid 30084629)
11. Corona G, Tzounis X, Dessì MA, Deiana M, Debnam ES, Visioli F and Spencer JPE. The fate of olive oil polyphenols in the gastrointestinal tract: implications of gastric and colonic microfl ora-dependent biotransformation. Free Radical Research 2006; 40: 647-658. (Pubitemid 43832520)
12. D' Angelo S, Manna C, Migliardi V, Mazzoni O, Morrica P, Capasso G, Pontoni G, Galletti P and Zappia V. Pharmacokinetics and metabolism of hydroxytyrosol, a natural antioxidant from olive oil. Drug Metabolism and Disposition: the Biological Fate of Chemicals 2001; 29: 1492-1498. (Pubitemid 33000698)
13. de la Torre K, Jauregui O, Castellote AI, Lamuela-Raventós RM, Covas MI, Casals I and López-Sabater MC. Rapid high-performance liquid chromatography-electrospray ionization tandem mass spectrometry method for qualitative and quantitative analysis of virgin olive oil phenolic metabolites in human low-density lipoproteins. Journal of Chromatography A 2006; 1116: 69-75.
14. de la Torre R. Bioavailability of olive oil phenolic compounds in humans. Infl ammopharmacology 2008; 16: 245-247.
15. Del Boccio P, Di Deo A, De Curtis A, Celli N, Iacoviello L and Rotilio D. Liquid chromatography-tandem mass spectrometry analysis of oleuropein and its metabolite hydroxytyrosol in rat plasma and urine after oral administration. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2002; 785: 47-56.
16. Edgecombe SC, Stretch GL and Hayball PJ. Oleuropein, an antioxidant polyphenol from olive oil, is poorly absorbed from isolated perfused rat intestine. The Journal of Nutrition 2000; 130: 2996-3002.
17. Furneri PM, Marino A, Saija A, Uccella N and Bisignano G. In vitro antimycoplasmal activity of oleuropein. International Journal of Antimicrobial Agents 2002; 20: 293-296.
18. Gariboldi P, Jommi G and Verotta L. Secoiridoids from Olea europaea. Phytochemistry 1986; 25: 865-869.
19. German JB and Walzem RL. The health benefi ts of wine. Annual Review of Nutrition 2000; 20: 561-593.
20. Hashimoto T, Ibi M, Matsuno K, Nakashima S, Tanigawa T, Yoshikawa T and Yabe-Nishimura C. An endogenous metabolite of dopamine 3,4- dihydroxyphenylethanol, acts as a unique cytoprotective agent against oxidative stress-induced injury. Free Radical Biology and Medicine 2004; 36: 555-564. (Pubitemid 38232678)
21. Howes MJR, Perry NSL and Houghton P. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytotherapy Research 2003; 17: 1-18. (Pubitemid 36205453)
22. Kanis JA. The incidence of hip fracture in Europe. Osteoporosis International 1993; 3: 10-15.
23. Lee-Huang S, Zhang L, Lin Huang P, Chang YT and Huang PL. Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochemical and Biophysical Research Communications 2003; 307: 1029-1037. (Pubitemid 36873821)
24. Manna C, Galletti P, Maisto G, Cucciolla V, D' Angelo S and Zappia V. Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco-2 cells. FEBS Letters 2000; 470: 341-344. (Pubitemid 30169289)
25. Manna C, D' Angelo S, Migliardi V, Loff redi E, Mazzoni O, Morrica P, Galletti P and Zappia V. Protective eff ect of the phenolic fraction from virgin olive oils against oxidative stress in human cells. Journal of Agricultural and Food Chemistry 2002; 50: 6521-6526.
26. Marrugat J, Covas MI, Fito M, Schroder H, Miró-Casas E, Gimeno E, Lopez-Sabater MC, de la Torre R and Farre M. Eff ects of diff ering phenolic content in dietary olive oils on lipids and LDL oxidation - a randomized controlled trial. European Journal of Nutrition 2004; 43: 140-147. (Pubitemid 38828662)
27. Martinez-Domingues E, de la Puerta R and Ruiz-Gutierrez V. Protective eff ects upon experimental infl ammation models of a polyphenolsupplemented virgin olive oil diet. Infl ammation Research 2001; 50: 102-106. (Pubitemid 32210151)
28. Micol V, Caturla N, Pérez-Fons L, Más V, Pérez L and Estepa A. The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Research 2005; 66: 129-136. (Pubitemid 40720118)
29. Miró-Casas E, Farré M, Covas MI, Fitó M, Lamuela Raventós RM and de la Torre R. Tyrosol bioavailability in humans after ingestion of virgin olive oil. Clinical Chemistry 2001a; 47: 341-343.
30. Miró-Casas E, Farré M, Covas MI, Ortuño Rodriguez J, Menoyo Colomer E, Lamuela Raventós RM and de la Torre R. Capillary gas chromatography-mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake. Analytical Biochemistry 2001b; 294: 63-72.
31. Miró-Casas E, Covas MI, Farré M, Fitó M, Ortuño J, Weinbrenner T, Roset P and de la Torre R. Hydroxytyrosol disposition in humans. Clinical Chemistry 2003a; 49: 945-952.
32. Miró-Casas E, Covas MI, Fitò M, Farré-Albadalejo M, Marrugat J and de la Torre R. Tyrosol and hydroxytyrosol are absorbed from moderate and sustained doses of virgin olive oil in humans. European Journal of Clinical Nutrition 2003b; 57: 186-190. (Pubitemid 36181813)
33. Moosmann B and Behl C. The antioxidant neuroprotective eff ects of estrogens and phenolic compounds are independent from their estrogenic properties. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 8867-8872. (Pubitemid 29374674)
34. Owen RW, Giacosa A, Hull WE, Haubner R, Würtele G, Spiegelhalder B and Bartsch H. Olive-oil consumption and health: the possible role of antioxidants. The Lancet Oncology 2000; 1: 107-112.
35. Puel C, Quintin A, Agalias A, Mathey J, Obled C, Mazur A, Davicco MJ, Lebecque P, Skaltsounis AL and Coxam V. Olive oil and its main phenolic micronutrient (oleuropein) prevent infl ammation-induced bone loss in the ovariectomised rat. British Journal of Nutrition 2004; 92: 119-127. (Pubitemid 38961280)
36. Reckner AR, Kuhnle G, Hu H, Roedig-Penman A, van der Braak MH, Moore KP and Rice-Evans CA. The metabolism of dietary polyphenols and the relevance to circulating levels of conjugated metabolites. Free Radical Research 2002; 36: 1229-1241. (Pubitemid 35230243)
37. Rios LY, Gonthier MP, Remesy C, Mila I, Lapierre C, Lazarus SA, Williamson G and Scalbert A. Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. American Journal of Clinical Nutrition 2003; 77: 912-918.
38. Ruiz-Gutiérrez V, Juan ME, Cert A and Planas JM. Determination of hydroxytyrosol in plasma by HPLC. Analytical Chemistry 2000; 72: 4458-4461.
39. Saija A and Uccella N. Olive biophenols: functional eff ects on human wellbeing. Trends in Food Science and Technology 2001; 11: 357-363.
40. Shasha B and Leibowitz J. On the oleuropein, the bitter principle of olives. The Journal of Organic Chemistry 1961; 26: 1948-1954.
41. Tan HW, Tuck KL, Stupans I and Hayball PJ. Simultaneous determination of oleuropein and hydroxytyrosol in rat plasma using liquid chromatography with fl uorescence detection. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2003; 785: 187-191. (Pubitemid 36078449)
42. Trichopoulou A, Katsouyanni K, Stuver S, Tzala L, Gnardellis C, Rimm E and Trichopoulos D. Consumption of olive oil and specifi c food groups in relation to breast cancer risk in Greece. Journal of the National Cancer Institute 1995; 87: 110-116.
43. Tsarbopoulos A, Gikas E, Papadopoulos N, Aligiannis N and Kafatos A. Simultaneous determination of oleuropein and its metabolites in plasma by high-performance liquid chromatography. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2003; 785: 157-164. (Pubitemid 36078446)
44. Tuck KL, Freeman MP, Hayball PJ, Strech GL and Stupans I. The in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labelled compounds to rats. The Journal of Nutrition 2001; 131: 1993-1996. (Pubitemid 32661069)
45. Tuck KL and Hayball PJ. Major phenolic compounds in olive oil: metabolism and health eff ects. The Journal of Nutritional Biochemistry 2002a; 13: 636-644.
46. Tuck KL, Hayball PJ and Stupans I. Structural characterization of the metabolites of hydroxytyrosol, the principal phenolic component in olive oil, in rats. Journal of Agricultural and Food Chemistry 2002b; 50: 2404-2409. (Pubitemid 34275317)
47. Urpi-Sarda M, Jauregui O, Lamuela-Raventos RM, Jaeger W, Miksits M, Covas MI, Antolovich M and Andres-Lacueva C. Uptake of diet resveratrol into the human low-density lipoprotein. identifi cation and quantifi cation of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Analytical Chemistry 2005; 77: 3149-3155. (Pubitemid 40695470)
48. Visioli F and Galli C. Antiatherogenic components of olive oil. Current Atherosclerosis Reports 2001; 3: 64-67.
49. Visioli F and Galli C. Biological properties of olive oil phytochemicals. Critical Reviews in Food Science and Nutrition 2002; 42: 209-221.
50. Visioli F, Galli C, Bornet F, Mattei A, Patelli R, Galli G and Caruso D. Olive oil phenolics are dose-dependently absorbed in humans. FEBS Letters 2000; 468: 159-160. (Pubitemid 30110787)
51. Vissers MN, Zock PL, Roodenburg AJC, Leenen R and Katan MB. Olive oil phenols are absorbed in humans. The Journal of Nutrition 2002; 132: 409-417. (Pubitemid 34208742)
52. Vissers MN, Zock PL and Katan MB. Bioavailability and antioxidant eff ects of olive oil phenols in humans: a review. European Journal of Clinical Nutrition 2004; 58: 955-965.
53. Weinbrenner T, Fitó M, de la Torre R, Saez GT, Rijken P, Tormos C, Coolen S, Albaladejo MF, Abanades S, Schroder H, Marrugat J and Covas MI. Olive oils high in phenolic compounds modulate oxidative/antioxidative status in men. The Journal of Nutrition 2004a; 134: 2314-2321. (Pubitemid 39201602)
54. Weinbrenner T, Fito M, Farre-Albaladejo M, Saez GT, Rijken P, Tormos C, Coolen S, de la Torre R and Covas MI. Bioavailability of phenolic compounds from olive oil and oxidative/antioxidant status at postprandial state in healthy humans. Drugs under Experimental and Clinical Research 2004b; 30: 207-212. (Pubitemid 40082995)